Modiin, Israel

Biolinerx Ltd.


USPTO Granted Patents = 19

% Expired Patents = 5.3


Trademarks = 3

Forward Citations = 32

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Amnon Peled (16 out of 38 patents)

silverMedal Yaron Pereg (13 out of 14 patents)

bronzeMedal Efrat Halbfinger (4 out of 5 patents)

4.  Ella Sorani (3 out of 3 patents)

5.  Ada Rephaeli (2 out of 15 patents)

6.  Irit Gil-Ad (2 out of 15 patents)

7.  Abraham Weizman (2 out of 13 patents)

8.  Abraham Nudelman (2 out of 46 patents)

9.  Osnat Bohana-Kashtan (1 out of 7 patents)

10.  Mazal Shaul (1 out of 2 patents)

11.  Ran Lifshitz (1 out of 1 patent)

12.  Ilan Winkler (1 out of 1 patent)

13.  Abi Vainstein-haras (1 out of 1 patent)

14.  Irit Gliko-Kabir (1 out of 1 patent)

15.  Michal Abraham (8 patents)


19 patents:

Company Overview
Biolinerx Ltd. is a biotechnology company based in Modiin, Israel, focused on developing innovative therapies for cancer and autoimmune diseases. The company specializes in the research and development of novel biologics and small molecules, leveraging advanced technologies to address unmet medical needs. Biolinerx aims to enhance treatment options through its proprietary platforms, fostering collaborations to accelerate the development of its therapeutic candidates and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

19 Patents

#2 in Modiin

#332 in Israel

#32,693 in the World

Modiin, IL
Modiin, Israel
Forward Citations = 32

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biolinerx Ltd.. Retrieved from https://idiyas.com/company/biolinerx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…